Scinai Immunotherapeutics Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	14.22	17.52	2.66	20.45	21.42	20.15	4.43	9.45	2.71	5.04
Short-Term Investments	0	0	0	0	0	0	2.71	0.57	0.57	0.57
Cash & Cash Equivalents	14.22	17.52	2.66	20.45	21.42	20.15	7.15	10.02	3.28	5.61
Cash Growth	-18.85%	558.76%	-87.00%	-4.50%	6.31%	181.87%	-28.64%	205.18%	-41.50%	-
Receivables	0	0	0.34	0.19	0.27	1.11	0.23	0.41	0.31	0.14
Other Current Assets	0.16	0.33	0	0	0	-0	0	0	0	0
Total Current Assets	14.37	17.84	3	20.64	21.69	21.25	7.38	10.42	3.59	5.75
Property, Plant & Equipment	12.7	14.19	12.93	11.89	7.97	1.56	0.41	0.58	0.74	0.93
Long-Term Investments	0	0	0	0	0	0	0.58	0.58	0.58	0.58
Other Long-Term Assets	0	0	0.13	0.14	0.21	0.25	0.13	0.08	0.3	0.04
Total Long-Term Assets	12.7	14.19	13.06	12.03	8.18	1.8	1.12	1.24	1.62	1.54
Total Assets	27.07	32.04	16.06	32.67	29.87	23.06	8.5	11.66	5.21	7.29
Accounts Payable	1.96	2.07	1.2	5.16	6.15	1.94	0.39	0.48	0.51	0.5
Current Debt	0.38	0.38	17.24	0.2	0	0	0	0	0	0
Other Current Liabilities	0	0	-0.32	0	0	0	0	0	0	0
Total Current Liabilities	2.34	2.44	18.12	5.35	6.15	1.94	0.39	0.48	0.51	0.5
Long-Term Debt	21.16	28.61	1.72	36.86	26.63	0	0	0	0	0
Other Long-Term Liabilities	5.33	0	0.35	8.82	5.9	5.24	0.88	1.71	0.02	0.02
Total Long-Term Liabilities	26.49	28.61	2.07	45.68	32.53	5.24	0.88	1.71	0.02	0.02
Total Liabilities	28.83	31.05	20.18	51.03	38.68	7.18	1.27	2.19	0.53	0.52
Total Debt	21.54	28.99	18.96	37.05	26.63	0	0	0	0	0
Debt Growth	-25.68%	52.90%	-48.84%	39.13%	-	-	-	-	-	-
Retained Earnings	-115.84	-110.04	-91.67	-90.42	-59.6	-34.83	-25.08	-22.49	-19.61	-17.42
Comprehensive Income	-2.01	-2.06	0	0	0	0	0	0	0	0.01
Shareholders' Equity	-1.76	0.98	-4.12	-18.36	-8.81	15.88	7.23	9.47	4.68	6.77
Net Cash / Debt	-7.33	-11.47	-16.3	-16.6	-5.22	20.15	7.15	10.02	3.28	5.61
Net Cash / Debt Growth	-	-	-	-	-	181.87%	-28.64%	205.18%	-41.50%	-
Net Cash Per Share	-0.01	-0.02	-0.04	-0.05	-0.02	0.10	0.05	0.09	0.06	0.12
Working Capital	12.03	15.4	-15.12	15.29	15.54	19.31	6.99	9.94	3.08	5.25
Book Value Per Share	-0.93	0.70	-3.72	-22.48	-13.48	31.59	21.41	35.89	34.50	56.48

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).